Selling functional food products on Amazon in the US market requires careful consideration of FDA classification, labeling rules, and the risk of enforcement action. Products that combine standard foods (e.g., coffee) with botanicals, vitamins, or minerals — or that make health claims — occupy a regulatory grey zone that directly affects how they can be listed, marketed, and structured on Amazon.
This article captures the strategic considerations surfaced during La Natura's US market planning. See [1] for client context.
Amazon listings must reflect accurate FDA product classification. The FDA distinguishes sharply between food and dietary supplements, and the distinction has significant consequences for what claims can be made and what ingredients are permitted.
A product likely requires supplement registration (rather than food listing) if it:
"Coffee is a standard food. It's not like there's a hundred different kinds of coffee. Coffee is coffee. And so the FDA doesn't like it when you take a standard food and try to turn it into something else." — Mark Hope
A June 2025 FDA update (the first since 2010) has increased enforcement activity, including more frequent warning letters for mislabeled dietary supplements and food products making unapproved claims. Products that may have been listed without issue previously now carry higher risk.
These can be listed under standard food categories on Amazon without supplement registration.
These should be listed under Amazon's dietary supplement category, which requires the factory/manufacturer to be registered with the FDA as a supplement manufacturer.
When a client has functional products that fall into the grey zone, there are three broad approaches to Amazon listing strategy:
Approach: Register the production facility as an FDA-compliant supplement manufacturer before listing.
Amazon impact: Enables full health claim usage in listings, A+ content, and product descriptions without enforcement risk.
Trade-offs:
- 6–9 month audit and registration process
- Delays time-to-market for the functional range
- Full compliance protects all other product listings from collateral risk
Approach: List functional products under food categories and make marketing claims, accepting the possibility of FDA warning letters.
Amazon impact: Faster to market; listings can use stronger claims initially. However, an FDA warning letter can force ASIN removal, account review, or a broader listing suspension.
Trade-offs:
- No registration delay
- High risk of forced removal; could disrupt the entire seller account if not isolated
- Other Amazon sellers in the same category demonstrably take this approach
"On Amazon, you see products where they're making crazy claims. I think what those companies are doing is they're just taking a risk." — Mark Hope
Approach: Incorporate a separate US company (e.g., "La Natura Supplements LLC") to own and operate the functional product listings on Amazon. The core brand's seller account remains insulated.
Amazon impact: Functional products are listed under a separate Amazon seller account. If FDA action occurs, only that account and those ASINs are affected. The main brand's account, reviews, and BSR history are protected.
Trade-offs:
- Requires new US company incorporation (~$1,000–$2,000)
- FDA facility registration still required (~$200), though audit risk may be lower for a new entity
- Separate Amazon seller account setup, brand registry, and listing build-out needed
- Brand naming decision required: use parent brand name or create a distinct supplement brand
"What you don't want to do is get in trouble with the FDA and have them say you have to pull all your products." — Mark Hope
If pursuing the separate entity route for Amazon:
| Item | Detail |
|---|---|
| US incorporation | ~$1,000–$2,000 (varies by state) |
| FDA facility registration | ~$200 |
| Amazon seller account | New account; separate from parent brand |
| Brand registry | New trademark or sub-brand may be needed |
| Bank account | Required for Amazon disbursements |
| Insurance | Separate product liability policy advisable |
The factory producing the functional products must still be registered with the FDA as a supplement manufacturer regardless of which entity is used for the Amazon listing.
When functional and non-functional products are being produced simultaneously, Amazon listing preparation should be sequenced to match production timelines. Request a consolidated product overview from the client including:
This allows listings, A+ content, and FBA shipment plans to be prepared in advance of stock arrival, minimising time between receipt and live listing.